Yumanity Therapeutics to Present at the Cowen and Company 39th Annual Health Care Conference


Yumanity Therapeutics, a company focused on discovering transformative therapies to treat neurodegenerative diseases, today announced that Tony Coles, M.D., chairman and chief executive officer, will present at the Cowen and Company 39th Annual Health Care Conference on Tuesday, March 12, 2019 at 8:00 a.m. EST at the Boston Marriott Copley Place in Boston, Massachusetts.

About Yumanity Therapeutics

Yumanity Therapeutics is transforming drug discovery for neurodegenerative diseases caused by protein misfolding. Formed in 2014 by renowned biotech industry leader, Tony Coles, M.D., and protein folding science pioneer, Susan Lindquist, Ph.D., the company is focused on discovering disease-modifying therapies for patients with Alzheimers disease, Parkinsons disease and amyotrophic lateral sclerosis (ALS). Leveraging its discovery engine, Yumanity Therapeutics innovative new approach to drug discovery and development concentrates on reversing the cellular phenotypes and disease pathologies caused by protein misfolding. For more information, please visit yumanity.com.

Media Contact:
W2O pure
Patrick Ryan
[email protected]